MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

Search

Verastem Inc

Open

9.02 0.89

Overview

Share price change

24h

Current

Min

8.86

Max

9.25

Key metrics

By Trading Economics

Income

26M

-26M

Sales

2.1M

2.1M

Profit margin

-1,213.57

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+70.45% upside

Dividends

By Dow Jones

Next Earnings

4 lis 2025

Market Stats

By TradingEconomics

Market Cap

377M

Previous open

8.13

Previous close

9.02

Verastem Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 maj 2025, 19:14 UTC

Major Market Movers

Verastem Ovarian-Cancer Drug Combination Gets FDA Approval -- Update

31 gru 2024, 19:15 UTC

Major Market Movers

Verastem Shares Soar on FDA Priority Review of Cancer Treatment

Peer Comparison

Price change

Verastem Inc Forecast

Price Target

By TipRanks

70.45% upside

12 Months Forecast

Average 15 USD  70.45%

High 20 USD

Low 13 USD

Based on 5 Wall Street analysts offering 12 month price targets forVerastem Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Verastem Inc

There is no Profile data available for 2VS.SG.
help-icon Live chat